Gilles de la Tourette syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
Histamine dysregulation was implicated as a rare cause of Tourette syndrome and other tic disorders a decade ago by a landmark genetic study in a high density family pedigree, which implicated a hypomorphic mutation in the histidine decarboxylase (Hdc) gene as a rare but high penetrance genetic cause.
|
30714121 |
2020 |
Gilles de la Tourette syndrome
|
0.680 |
Biomarker
|
disease |
BEFREE |
In the current study we investigated if mice lacking the histamine producing enzyme HDC share the morphological and cytological phenotype with GTS patients by using magnetic resonance (MRI) and diffusion tensor imaging (DTI), unbiased stereology and immunohistochemistry.
|
28681514 |
2017 |
Gilles de la Tourette syndrome
|
0.680 |
Biomarker
|
disease |
BEFREE |
A rare mutation in the enzyme that produces histamine (HA), histidine decarboxylase (HDC), has been identified in patients with Tourette syndrome (TS).
|
28584117 |
2017 |
Gilles de la Tourette syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
In this study, we investigated the role of the histidine decarboxylase gene (HDC) in TS susceptibility in the Chinese Han population.
|
27529419 |
2016 |
Gilles de la Tourette syndrome
|
0.680 |
Biomarker
|
disease |
MGD |
These data confirm histidine decarboxylase deficiency as a rare cause of TS and identify HA-DA interactions in the basal ganglia as an important locus of pathology.
|
24411733 |
2014 |
Gilles de la Tourette syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
A rare genetic form of Tourette syndrome due to L-histidine-decarboxylase mutation, with similar features in human and rodent, has inspired new research on functional anatomy of Tourette syndrome.
|
24978639 |
2014 |
Gilles de la Tourette syndrome
|
0.680 |
Biomarker
|
disease |
BEFREE |
These data confirm histidine decarboxylase deficiency as a rare cause of TS and identify HA-DA interactions in the basal ganglia as an important locus of pathology.
|
24411733 |
2014 |
Gilles de la Tourette syndrome
|
0.680 |
GeneticVariation
|
disease |
BEFREE |
No significant differences in genotypic and allele distribution between patients and controls for these three variants (P = 0.274, P = 1.000 and P = 0.632 for genotypic distribution, respectively; P = 0.143, P = 1.000 and P = 0.582 for allele distribution, respectively) were observed, suggesting variants in the HDC gene may play little or no role in TS susceptibility in Chinese Han population.
|
22095709 |
2012 |
Gilles de la Tourette syndrome
|
0.680 |
Biomarker
|
disease |
BEFREE |
L-histidine decarboxylase and Tourette's syndrome.
|
20445167 |
2010 |
Gilles de la Tourette syndrome
|
0.680 |
Biomarker
|
disease |
MGD |
Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
|
16212954 |
2005 |
Gilles de la Tourette syndrome
|
0.680 |
Biomarker
|
disease |
MGD |
Mice lacking histidine decarboxylase exhibit abnormal mast cells.
|
11478947 |
2001 |
Gilles de la Tourette syndrome
|
0.680 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Gilles de la Tourette syndrome
|
0.680 |
Biomarker
|
disease |
CTD_human |
|
|
|
Colorectal Carcinoma
|
0.310 |
Biomarker
|
disease |
BEFREE |
Histidine decarboxylase (HDC) deficiency has been shown to promote inflammation-associated colorectal cancer by accumulation of CD11b<sup>+</sup>Gr-1<sup>+</sup> immature myeloid cells, indicating a potential antitumorigenic effect of histamine.
|
28917668 |
2017 |
Colorectal Carcinoma
|
0.310 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Hepatomegaly
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.
|
28108177 |
2017 |
Rhinitis
|
0.210 |
GeneticVariation
|
disease |
BEFREE |
The HDC allele Glu644 in homozygosity increases the risk of developing rhinitis in the studied population.
|
20608921 |
2010 |
Rhinitis
|
0.210 |
Biomarker
|
disease |
RGD |
Increase in the level of histidine decarboxylase mRNA expression in nasal mucosa of rats sensitized by toluene diisocyanate.
|
15054596 |
2004 |
Aggressive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Echolalia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sleep disturbances
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Obsessive compulsive behavior
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dyssomnias
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Tic, Motor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tic, Vocal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|